PolyPid Ltd. (PYPD)
5.01
-0.09
(-1.76%)
USD |
NASDAQ |
Aug 26, 12:18
PolyPid Shareholders Equity (Quarterly) : 5.388M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.388M |
| March 31, 2026 | 8.78M |
| December 31, 2025 | 10.97M |
| September 30, 2025 | 15.36M |
| June 30, 2025 | 20.48M |
| March 31, 2025 | 0.086M |
| December 31, 2024 | 7.684M |
| September 30, 2024 | 2.158M |
| June 30, 2024 | 1.601M |
| March 31, 2024 | 7.145M |
| December 31, 2023 | -2.096M |
| September 30, 2023 | 3.538M |
| June 30, 2023 | 8.347M |
| Date | Value |
|---|---|
| March 31, 2023 | 11.41M |
| December 31, 2022 | 5.829M |
| September 30, 2022 | 11.50M |
| June 30, 2022 | 19.11M |
| March 31, 2022 | 28.84M |
| December 31, 2021 | 35.96M |
| September 30, 2021 | 48.12M |
| June 30, 2021 | 56.88M |
| March 31, 2021 | 66.15M |
| December 31, 2020 | 72.78M |
| September 30, 2020 | 79.23M |
| June 30, 2020 | 84.48M |
| March 31, 2020 | 13.00M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 7.753B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 35.64M |
| Purple Biotech Ltd. | 12.27M |
| Sol-Gel Technologies Ltd. | 48.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.23M |
| Total Liabilities (Quarterly) | 9.846M |
| Debt to Equity Ratio | 0.2918 |
| Current Ratio | 1.346 |
| Net Debt Paydown Yield | 1.41% |